IL75990A - Stable crystal modification of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate,process for its manufacture and pharmaceutical compositions containing it - Google Patents
Stable crystal modification of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate,process for its manufacture and pharmaceutical compositions containing itInfo
- Publication number
- IL75990A IL75990A IL75990A IL7599085A IL75990A IL 75990 A IL75990 A IL 75990A IL 75990 A IL75990 A IL 75990A IL 7599085 A IL7599085 A IL 7599085A IL 75990 A IL75990 A IL 75990A
- Authority
- IL
- Israel
- Prior art keywords
- diphosphonate
- hydroxypropane
- disodium
- amino
- manufacture
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- CEYUIFJWVHOCPP-UHFFFAOYSA-L disodium;(3-amino-1-hydroxy-1-phosphonatopropyl)phosphonic acid Chemical compound [Na+].[Na+].NCCC(O)(P(O)([O-])=O)P(O)([O-])=O CEYUIFJWVHOCPP-UHFFFAOYSA-L 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
- C07F9/165—Esters of thiophosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH376884 | 1984-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL75990A true IL75990A (en) | 1989-07-31 |
Family
ID=4263070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL75990A IL75990A (en) | 1984-08-06 | 1985-08-01 | Stable crystal modification of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate,process for its manufacture and pharmaceutical compositions containing it |
Country Status (26)
Country | Link |
---|---|
US (2) | US4639338A (fr) |
EP (1) | EP0177443B1 (fr) |
JP (1) | JPS6143196A (fr) |
KR (1) | KR940000817B1 (fr) |
AR (4) | AR240832A1 (fr) |
AT (1) | ATE47396T1 (fr) |
AU (1) | AU591066B2 (fr) |
CA (1) | CA1255694A (fr) |
CY (1) | CY1570A (fr) |
DD (1) | DD239597A5 (fr) |
DE (1) | DE3573783D1 (fr) |
DK (1) | DK167282B1 (fr) |
DO (1) | DOP1990004769A (fr) |
ES (2) | ES8701188A1 (fr) |
FI (1) | FI79712C (fr) |
GR (1) | GR851910B (fr) |
HK (1) | HK42591A (fr) |
HU (1) | HU193124B (fr) |
IE (1) | IE58077B1 (fr) |
IL (1) | IL75990A (fr) |
MX (1) | MX9203373A (fr) |
NO (1) | NO165401C (fr) |
PH (1) | PH24854A (fr) |
PT (1) | PT80916B (fr) |
SG (1) | SG91390G (fr) |
ZA (1) | ZA855892B (fr) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH664158A5 (fr) * | 1984-07-18 | 1988-02-15 | Symphar Sa | Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant. |
DE3770982D1 (de) * | 1986-04-24 | 1991-08-01 | Fujisawa Pharmaceutical Co | Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel. |
IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
US4963681A (en) * | 1987-07-06 | 1990-10-16 | Norwich Eaton Pharmaceuticals, Inc. | Process for synthesis of aminomethylene phosphonoalkylphosphinates |
IT1222734B (it) * | 1987-09-25 | 1990-09-12 | Scalvo S P A | Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina |
PH26923A (en) * | 1989-03-08 | 1992-12-03 | Ciba Geigy | N-substituted amino alkanediphosphonic acids |
US4922007A (en) * | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
US5019651A (en) * | 1990-06-20 | 1991-05-28 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof |
EP0541037A3 (en) * | 1991-11-06 | 1997-02-26 | Takeda Chemical Industries Ltd | Squalene synthetase inhibitory composition and use thereof |
US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
TW237386B (fr) | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
US6406714B1 (en) | 1992-12-02 | 2002-06-18 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids |
JP3266395B2 (ja) * | 1993-11-24 | 2002-03-18 | 富士写真フイルム株式会社 | 有機薬品の晶析方法 |
TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
US20010007863A1 (en) | 1998-06-18 | 2001-07-12 | Merck & Co., Inc. | Wet granulation formulation for bisphosphonic acids |
GB9408775D0 (en) * | 1994-05-04 | 1994-06-22 | Ciba Geigy Ag | Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration |
DE19719680A1 (de) | 1997-05-09 | 1998-11-19 | Boehringer Mannheim Gmbh | Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz |
PT891979E (pt) * | 1997-07-15 | 2005-02-28 | Gador Sa | Uma forma cristalina do mono-hidrato do sal monossodico do acido n,n-dimetil-3-amino-1-hidroxipropan-1,1-difosfonico e o procedimento para a sua preparacao |
EP1702924A3 (fr) * | 1998-08-27 | 2007-07-18 | Teva Pharmaceutical Industries Ltd | Formes de type hydrate du sel de sodium de l'alendronate, procédés de préparation et compositions pharmaceutiques |
BR9913472A (pt) | 1998-08-27 | 2002-03-05 | Teva Pharma | Novas formas hidratadas de alendronato de sódio, seus processos de fabricação e suas composições farmacêuticas |
EP0998933A1 (fr) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Procédé pour la préparation de compositions pharmaucetiques contenant des diphosphonates pour administration orale |
EP0998932A1 (fr) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Forme d'administration pharmaceutique contenant des diphosphonates ou leurs sels et méthode pour la fabriquer |
US6794536B1 (en) | 1998-12-10 | 2004-09-21 | Aesqen, Inc. | Method for preparation of disodium pamidronate |
ATE238315T1 (de) * | 1998-12-10 | 2003-05-15 | Aesgen Inc | Verfahren zur herstellung von dinatriumpamidronat |
US6160165A (en) * | 1998-12-10 | 2000-12-12 | Aesgen, Inc. | Method for preparation of disodium pamidronate |
US6143919A (en) * | 1999-05-18 | 2000-11-07 | 3M Innovative Properties Company | Polymerizable acidic compounds and methods of preparation |
US6315566B1 (en) | 1999-05-18 | 2001-11-13 | 3M Innovative Properties Company | Dental materials |
US6963008B2 (en) * | 1999-07-19 | 2005-11-08 | Teva Pharmaceutical Industries Ltd. | Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
ES2153794B1 (es) * | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
KR100343232B1 (ko) * | 1999-12-10 | 2002-07-10 | 김재윤 | 결정성 파미드론산 이나트륨염 수화물과 그의 제조방법 |
PL360910A1 (en) * | 2000-09-18 | 2004-09-20 | F H Faulding & Co Limited | Diphosphonate solutions |
WO2002058708A1 (fr) * | 2001-01-23 | 2002-08-01 | Gador S.A. | Composition comprenant des diphosphonates pour la prevention et/ou le traitement de maladies metaboliques des os, procede de preparation d'une telle composition et son utilisation |
MXPA03009890A (es) | 2001-05-02 | 2004-02-17 | Sicor Inc | Pamidronato disodico inyectable. |
CA2372450A1 (fr) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Preparation injectable liquide de pamidronate disodique |
ITMI20012751A1 (it) * | 2001-12-21 | 2003-06-21 | Lyogen Ltd | Sale monosodico dell'acido pamidronico e procedimento per la sua preparazione |
CA2470495A1 (fr) * | 2001-12-24 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | Forme posologique avec pastille noyau de principe actif enrobee dans un corps annulaire comprime de poudre ou de substance granulaire, et procede et outils pour la production de cette forme posologique |
US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
AU2003217676B2 (en) | 2002-02-22 | 2009-06-11 | Takeda Pharmaceutical Company Limited | Active agent delivery systems and methods for protecting and administering active agents |
US20040138180A1 (en) * | 2002-10-03 | 2004-07-15 | Barr Laboratories, Inc. | Bisphosphonate composition and process for the preparation thereof |
PT1790347E (pt) * | 2002-12-20 | 2015-02-05 | Hoffmann La Roche | Formulação de ibandronato a dose elevada |
US20050119230A1 (en) * | 2003-09-18 | 2005-06-02 | Alexandra Glausch | Pharmaceutical products comprising bisphosphonated |
WO2005054260A1 (fr) * | 2003-12-04 | 2005-06-16 | Mustafa Nevzat Ilac Sanayii A.S. | Procedes de production de pamidronate de disodium pur |
SI1753395T1 (sl) | 2004-05-24 | 2011-01-31 | Warner Chilcott Co Llc | Enterične trdne formulacije oralnih odmerkov bifosfonata, ki vsebuje kelirno sredstvo |
WO2006039721A2 (fr) * | 2004-10-08 | 2006-04-13 | The Board Of Trustees Of The University Of Illinois | Composes de bisphosphonate et methodes de traitement de maladies de resorption osseuse, de cancers, de douleurs osseuses, de troubles immunitaires et de maladies infectieuses |
WO2008128056A1 (fr) * | 2004-10-08 | 2008-10-23 | The Board Of Trustees Of The University Of Illinois | Composés bisphosphonates et procédés présentant un potentiel amélioré pour cibles multiples incluant fpps, ggpps, et dpps |
JP2009530414A (ja) * | 2006-03-17 | 2009-08-27 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ | ビスホスホネート化合物及び方法 |
US20100144679A1 (en) * | 2007-03-21 | 2010-06-10 | Duke University | Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture |
CA2708281A1 (fr) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Inhibiteurs de metalloenzymes utilisant des fractions de liaison a un metal en combinaison avec des fractions de ciblage |
ES2537216T3 (es) | 2009-09-01 | 2015-06-03 | Duke University | Composiciones de bisfosfonato y métodos para tratar la insuficiencia cardíaca |
FR2954320B1 (fr) | 2009-12-17 | 2012-06-15 | Cll Pharma | Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels |
CA2795886A1 (fr) | 2010-04-16 | 2011-10-20 | Novartis Ag | Procedes et compositions pour ameliorer l'osteointegration d'implant |
JP6261512B2 (ja) | 2011-11-16 | 2018-01-17 | デューク ユニバーシティ | 心機能障害を治療及び/又は低減するためのビスホスホネート組成物並びに方法 |
GB201200868D0 (en) | 2012-01-19 | 2012-02-29 | Depuy Int Ltd | Bone filler composition |
CA2873742C (fr) * | 2012-05-14 | 2018-01-16 | Antecip Bioventures Ii Llc | Compositions comprenant de l'acide zoledronique ou des composes apparentes permettant de soulager une douleur inflammatoire et des etats associes |
US11654152B2 (en) | 2012-05-14 | 2023-05-23 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
KR101995432B1 (ko) * | 2016-10-13 | 2019-07-02 | 엘지전자 주식회사 | 공기조화기 및 그 제어방법 |
EP3553067A1 (fr) * | 2018-04-10 | 2019-10-16 | Abiogen Pharma S.p.A. | Polymorphe de néridronate de sodium et son procédé de préparation |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2130794C3 (de) * | 1971-06-22 | 1974-07-11 | Joh. A. Benckiser Gmbh, 6700 Ludwigshafen | Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure |
DE2405254C2 (de) * | 1974-02-04 | 1982-05-27 | Henkel KGaA, 4000 Düsseldorf | Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper |
US4134969A (en) * | 1974-02-04 | 1979-01-16 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Method of treatment of calcium disorders using aminoalkane-diphosphonic acids |
DE2534391C2 (de) * | 1975-08-01 | 1983-01-13 | Henkel KGaA, 4000 Düsseldorf | 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren |
SE7612534L (sv) * | 1975-12-01 | 1977-06-02 | Henkel & Cie Gmbh | Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning |
DE2553963A1 (de) * | 1975-12-01 | 1977-06-08 | Henkel & Cie Gmbh | Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels |
JPS5283957A (en) * | 1975-12-01 | 1977-07-13 | Henkel & Cie Gmbh | Medicine for treating metabolic obstruction of calcium |
SE409706B (sv) * | 1976-05-21 | 1979-09-03 | Astra Pharma Prod | Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat |
DE2702631A1 (de) * | 1977-01-22 | 1978-07-27 | Henkel Kgaa | Verfahren zur herstellung von 1-hydroxy-3-amino-propan-1,1-diphosphonsaeuren |
DE2943498C2 (de) * | 1979-10-27 | 1983-01-27 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure |
DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
US4304734A (en) * | 1980-10-16 | 1981-12-08 | Vysoka Skola Chemicko-Technologicka | 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof |
DE3151038A1 (de) * | 1981-12-23 | 1983-07-28 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure |
US4446052A (en) * | 1982-05-17 | 1984-05-01 | The Procter & Gamble Company | Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate |
CH664158A5 (fr) * | 1984-07-18 | 1988-02-15 | Symphar Sa | Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant. |
-
1985
- 1985-07-29 US US06/759,985 patent/US4639338A/en not_active Expired - Lifetime
- 1985-07-30 AT AT85810352T patent/ATE47396T1/de not_active IP Right Cessation
- 1985-07-30 DE DE8585810352T patent/DE3573783D1/de not_active Expired
- 1985-07-30 EP EP85810352A patent/EP0177443B1/fr not_active Expired
- 1985-08-01 IL IL75990A patent/IL75990A/xx not_active IP Right Cessation
- 1985-08-01 PH PH32593A patent/PH24854A/en unknown
- 1985-08-02 CA CA000488039A patent/CA1255694A/fr not_active Expired
- 1985-08-02 IE IE193185A patent/IE58077B1/en not_active IP Right Cessation
- 1985-08-02 FI FI852986A patent/FI79712C/fi not_active IP Right Cessation
- 1985-08-05 NO NO853087A patent/NO165401C/no not_active IP Right Cessation
- 1985-08-05 AU AU45777/85A patent/AU591066B2/en not_active Expired
- 1985-08-05 HU HU842978A patent/HU193124B/hu unknown
- 1985-08-05 PT PT80916A patent/PT80916B/pt unknown
- 1985-08-05 JP JP60171301A patent/JPS6143196A/ja active Granted
- 1985-08-05 DK DK355485A patent/DK167282B1/da not_active IP Right Cessation
- 1985-08-05 ZA ZA855892A patent/ZA855892B/xx unknown
- 1985-08-05 DD DD85279373A patent/DD239597A5/de not_active IP Right Cessation
- 1985-08-05 KR KR1019850005620A patent/KR940000817B1/ko not_active IP Right Cessation
- 1985-08-05 GR GR851910A patent/GR851910B/el unknown
- 1985-08-05 ES ES545899A patent/ES8701188A1/es not_active Expired
- 1985-08-06 AR AR301204A patent/AR240832A1/es active
-
1986
- 1986-06-02 ES ES555602A patent/ES8706707A1/es not_active Expired
- 1986-09-08 US US06/905,097 patent/US4711880A/en not_active Expired - Lifetime
-
1989
- 1989-06-29 AR AR89314299A patent/AR244696A1/es active
- 1989-06-29 AR AR89314298A patent/AR244698A1/es active
- 1989-06-29 AR AR89314300A patent/AR244697A1/es active
-
1990
- 1990-11-13 SG SG913/90A patent/SG91390G/en unknown
- 1990-11-20 DO DO1990004769A patent/DOP1990004769A/es unknown
-
1991
- 1991-05-30 HK HK425/91A patent/HK42591A/xx not_active IP Right Cessation
- 1991-12-20 CY CY1570A patent/CY1570A/xx unknown
-
1992
- 1992-06-25 MX MX9203373A patent/MX9203373A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL75990A (en) | Stable crystal modification of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate,process for its manufacture and pharmaceutical compositions containing it | |
PT86366A (en) | Process for the preparation of phosphinic acid derivatives and of pharmaceutical compositions containing the same | |
PT81746A (en) | Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them | |
HUT40453A (en) | Process for producing 11-beta-phenyl-gonanes and pharmaceutical compositions containing them | |
HUT41772A (en) | Process for producing /4-substituted-piperazinyl- and -homopiperazinyl/-pyridazines and pharmaceutical compositions containing them | |
PH24334A (en) | Process for the preparation of a lyophilisate composition containing oxicam derivatives | |
PT82294B (en) | Process for the preparation of arylethanolamine derivatives and of pharmaceutical compositions containing the same | |
GB2167746B (en) | A process for the preparation of isosilybin-free silibinin and pharmaceutical compositions containing it | |
PT76523B (en) | Process for preparing phenoxyalkylcarboxylic acid derivatives and of pharmaceutical compositions containing the same | |
PT81502A (en) | Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same | |
PT80794A (en) | Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same | |
PT81842B (en) | Process for the manufacture of polycyclic and of pharmaceutical compositions containing the same | |
HUT38367A (en) | Process for producing epoxy-steroides and pharmaceutical compositions containing them | |
PT79858A (en) | Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith | |
PT75042A (en) | Process for the preparation of apovincaminates and pharmaceutical compositions containing them | |
HUT39142A (en) | Process for producing naphtyl-analogues of mevalolactone and derivatives and pharmaceutical compositions containing them | |
HUT41762A (en) | Process for producing thieno-benzo-pyranes, -thiopyranes and naphtothiophenes and pharmaceutical compositions containing them | |
GB2081708B (en) | Novel derivatives of (1-benzyl-1h-indazol-3-yl) oxyacetic acid and pharmaceutical composition containing it | |
PT80876A (en) | Process for the preparation of phenyl nonatetraenoic acid deri-vatives and of pharmaceutical compositions containing the same | |
PT81083A (en) | Process for the preparation of substituted 7-oxomitosanes and of pharmaceutical compositions containing the same | |
HUT39438A (en) | Process for producing naphtoxazine derivatives and pharmaceutical compositions containing them | |
HUT37746A (en) | Process for producing cycloalkane-indene-carboximide-amide derivatives and pharmaceutical compositions containing them | |
HUT37155A (en) | Process for producing n-acylized 1-lakyl-amino-1-deoxy-ketoze derivatives and pharmaceutical compositions containing them | |
PT80799B (en) | Aminoeburnanecarboxylic acid derivatives pharmaceutical compositions containing them and process for preparing same | |
PT80800A (en) | Nitroapovincaminic acid derivatives pharmaceutical compositions containing them and process for preparing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |